Page 15 - Codexis Inc News Today

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Thursday reported a loss of $22.6 million in its first quarter. On a per-share basis, the Redwood City, California-based company said it had a loss of 34 cents.

Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant drop in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a drop of 11.0% from the March 31st total of 4,890,000 shares. Currently, 6.9% of the shares of the stock are short sold. Based on an […]

Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a decrease of 11.0% from the March 31st total of 4,890,000 shares. Approximately 6.9% of the company’s stock are short sold. Based on an average trading […]

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market - A Global and Regional Analysis: Focus on Chemical Synthesis...

/PRNewswire/ -- The "Nucleic Acid Therapeutics CDMO Market - A Global and Regional Analysis: Focus on Chemical Synthesis Method, Product, Technology, End User,...

/PRNewswire/ -- The industrial enzymes market size is forecasted to increase by USD 2,190.59 million from 2022 to 2027, at a CAGR of 6.26%, according to the...

Global Biocatalysts Market Report, And Forecasts 2023-2029 Bharat Book Bureau Provides the Trending Market Research Report on Global Biocatalysts…

Global Specialty Enzymes Market Size, Growth, Opportunities Analysis, And Forecast To 2018-2028 Bharat Book Bureau Provides the Trending Market…

ARK Investment Management LLC lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 7.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,941,985 shares of the biotechnology company’s stock after selling 331,500 shares during the period. ARK […]

Biocatalyst industry is anticipated to register 6.4% CAGR between 2023 and 2032 due to growing biofuel demand....